News & Events

Cyril d’Arros receives an award for his oral presentation at Bioceramics31

: Biomatlante News; 04 December 2019

Congratulations from Biomatlante team!

BIOMATLANTE joins the AMS Group

: Biomatlante News; 03 December 2019

Biomatlante is very pleased to announce the acquisition of 100% of its shares by Advanced Medical Solutions Group plc (London Alternative Investment Market: AMS).

Biomatlante: a new step towards the MDR

: Biomatlante News; 03 July 2019

Just after BSI last January, TÜV Süd Product Service GmbH is now the second Notified Body designated to issue CE Marking certifications under the European Medical Devices Regulation (MDR).

Biomatlante receives MDSAP Accreditation

: Biomatlante News; 06 March 2019

Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the obtention of the MDSAP^* accreditation on the new ISO 13485:2016 Certificate.

BIOMATLANTE announces the appointment of its new CEO

: Biomatlante News; 01 February 2019

Julien Dert named as new CEO of Biomatlante, Chantal Gobin continues as Chairman of the Board

Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the appointment of its new CEO, Julien Dert, being effective on February 1st, 2019.

Clinical Performance of hydrogel- bioceramic Putty for Bone Regeneration in maxillofacial surgery

: Biomatlante News; 27 March 2018

The article shows the valorization of results of a non interventional clinical study of 78 patients with the product In’Oss™ in association with a collagen resorbable membrane in maxillofacial surgery. The safety and efficacy of In’Oss has been demonstrated, as well as the performance of EZ Cure membrane associated to it.